bioMérieux S.A. (OTCMKTS:BMXMF) Sees Large Growth in Short Interest

bioMérieux S.A. (OTCMKTS:BMXMF) saw a significant growth in short interest in the month of November. As of November 30th, there was short interest totalling 139,000 shares, a growth of 6.6% from the November 15th total of 130,400 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 1,390.0 days.

Analyst Ratings Changes

Separately, UBS Group raised shares of bioMérieux to a “strong-buy” rating in a research note on Thursday, August 22nd.

bioMérieux Price Performance

Shares of BMXMF traded up $0.93 during trading on Monday, reaching $107.03. 100 shares of the company traded hands, compared to its average volume of 337. bioMérieux has a twelve month low of $93.50 and a twelve month high of $122.52. The stock has a 50-day simple moving average of $108.32 and a 200-day simple moving average of $107.61.

bioMérieux Company Profile

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.